Welcome to our dedicated page for Lakeside Holding SEC filings (Ticker: LSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Lakeside Holding Limited (Nasdaq: LSH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Lakeside identifies itself in these filings as a Nevada-incorporated, U.S.-based integrated cross-border supply chain solution provider and emerging growth company whose common stock trades on The Nasdaq Stock Market LLC.
For investors analyzing LSH, key documents include annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe Lakeside’s cross-border freight solutions under the American Bear Logistics brand and its pharmaceutical distribution activities through Hupan Pharmaceutical (Hubei) Co., Ltd. These reports detail revenue composition between third-party and related-party cross-border freight solutions, the contribution from pharmaceutical product distribution, and revenue by customer geographic location.
Current reports on Form 8-K provide timely information about material events, such as the acquisition of Hupan Pharmaceutical, private placements of common stock, convertible debt financings, Nasdaq listing compliance notices, and changes in directors and executive officers. An 8-K also documents that Lakeside’s common stock is listed on Nasdaq under the symbol LSH and that the company is treated as an emerging growth company. Notifications of late filing on Form 12b-25 (NT 10-Q) explain any delays in quarterly report submissions and the expected timing of those filings.
Lakeside’s proxy materials on Schedule 14A outline proposals for stockholder approval, including amendments to the articles of incorporation and bylaws, increases in authorized common stock, authorization of preferred stock, adoption of a treasury reserve strategy, approval of potential future issuances of common stock or convertible securities, and adoption of equity incentive plans. These documents provide insight into the company’s capital structure and governance framework.
On Stock Titan, AI-generated summaries highlight the main points from each filing, helping readers quickly understand topics such as segment disclosures, financing terms, listing status, and board changes. Real-time updates from EDGAR ensure that new LSH filings, including Forms 10-K, 10-Q, 8-K, DEF 14A, and any insider transaction reports on Form 4, are accessible as soon as they are available, with plain-language explanations to support deeper research into Lakeside’s logistics and pharmaceutical distribution businesses.
Lakeside Holding (Nasdaq: LSH) filed a Form 8-K disclosing that on June 24 2025 it executed a Securities Purchase Agreement with several investors for a private placement of 3,000,000 common shares at $1.00 per share, generating approximately $3.0 million in gross proceeds.
The shares are being issued under the Section 4(a)(2)/Regulation S exemptions and therefore are unregistered securities subject to transfer restrictions. Proceeds are earmarked for general corporate purposes. The agreement contains customary representations, warranties and covenants and is included as Exhibit 10.1.
The filing also triggers Item 3.02 disclosure for unregistered sales of equity securities. No additional financial statements, pro-formas, or risk factors were provided, and no other material events were reported.